Otsuka_Patient_Assistance_Foundation_KO_Logo Otsuka_Patient_Assistance_Foundation_KO_Logo ABILIFY MAINTENA® (aripiprazole) JYNARQUE® (tolvaptan) REXULTI® (brexpiprazole) SAMSCA® (tolvaptan) $ R x

FAQs

Below are frequently asked questions about the Otsuka Patient Assistance Foundation, Inc. (OPAF). The FAQs provide guidance to patients, caregivers, and healthcare professionals (HCPs). If you have further questions, please call us at 1-855-727-6274.

General FAQs

The Otsuka Patient Assistance Foundation, Inc (OPAF) is a nonprofit 501c(3) organization that provides free treatment to eligible uninsured and underinsured patients that have been prescribed ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension, JYNARQUE®(tolvaptan) tablets, REXULTI®(brexpiprazole) tablets, or SAMSCA®(tolvaptan) tablets medications.

OPAF is funded by donations. Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.

The OPAF Resource and Solutions Center may help patients find local, state, and national resources which are not affiliated with OPAF. These alternative organizations may be able to help with other concerns such as other medication and medical financial assistance, disease state educational material, other financial assistance, transportation assistance, housing assistance, and nutritional assistance. You can reach the OPAF Resource and Solutions Center at 1-855-727-6274, Monday-Friday, 8 AM-8 PM (ET) and speak with one of our Patient Assistance Advocates.

Patient & Caregiver FAQs

Yes, you can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. When submitting your information into the portal, please be sure to upload all of the required documentation such as income verification, US home address verification, and insurance denial information.

Please provide your HCP proof of income for all members of the household who file a tax return.

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:

  • Federal Income Tax Return (1040, etc.)
  • W-2 from previous tax year
  • 1099-MISC form
  • Two most recent paystubs
  • Social Security award letter
  • Disability income information
  • Unemployment benefits letter
  • Letter from employer on company letterhead

The application must also include an acceptable proof of a US address. Acceptable documentation includes one of the following:

  • Social Security number
  • State driver’s license or State ID
  • US birth certificate
  • US passport
  • Mortgage statement or rental agreement
  • Two (2) utility bills
  • Foreign passport with US visa
  • I-94 form with photograph
  • US military ID
  • US certificate of naturalization or citizenship
  • Green card
  • Alien registration card

The application must also include insurance denial documentation. Acceptable documentation includes one of the following:

  • Explanation of benefits
  • Insurance statement
  • Prior authorization denial letter

Once all of the documentation and the application are submitted to OPAF, the application will go through an eligibility approval process. Once the application has completed the eligibility approval process, the OPAF team will notify you, as well as your Healthcare Professional [HCP] what the application approval decision is. If approved, the next steps are receiving your medication at no cost. OPAF will review the application to ensure that it is complete. If additional information is required, OPAF will contact your healthcare professional.

Once the application and all documentation has been received, OPAF will provide your healthcare professional a determination of benefits within 48 hours. OPAF cannot process an application without all documentation. If there is missing information or documentation, the application may take longer to process and possibly could be denied after 90 days.

If you have any questions, please call our Dedicated Patient Case Coordinators. They can be reached at 1-855-727-6274, Monday-Friday, 8 AM-8 PM (ET).

Healthcare Professional FAQs

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return.

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:

  • Federal Income Tax Return (1040, etc.)
  • W-2 from previous tax year
  • 1099-MISC form
  • Two most recent paystubs
  • Social Security award letter
  • Disability income information
  • Unemployment benefits letter
  • Letter from employer on company letterhead

The application must also include an acceptable proof of a US address. Acceptable documentation includes one of the following:

  • Social Security number
  • State driver’s license or State ID
  • US birth certificate
  • US passport
  • Mortgage statement or rental agreement
  • Two (2) utility bills
  • Foreign passport with US visa
  • I-94 form with photograph
  • US military ID
  • US certificate of naturalization or citizenship
  • Green card
  • Alien registration card

The application must also include insurance denial documentation. Acceptable documentation includes one of the following:

  • Explanation of benefits
  • Insurance statement
  • Prior authorization denial letter

Patients that are enrolled with OPAF and have government-issued insurance such as Medicare, Medicare Part D, Medicaid are eligible for assistance up to December 31st of each calendar year. Patients that have non-government issued insurance or are uninsured are eligible to receive assistance for a rolling 12-month period. One month prior to their enrollment ending, a new application can be submitted for the following enrollment period.

If a patient is enrolled in OPAF’s temporary patient assistance program, natural disaster relief, or COVID-19 relief, they will receive free medication for 90 days with an option to reapply if needed.

The medication shipment location is determined by the medication selected in the application and/or the Healthcare Professionals [HCP] discretion. Patients prescribed ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension must have the medication shipped to a Healthcare Professional’s office or a Local Care Center for administration. JYNARQUE®(tolvaptan) tablets, REXULTI®(brexpiprazole) tablets, or SAMSCA®(tolvaptan) tablets may be shipped to either the Provider’s office or to the patient’s home.

Yes, patients must have a diagnosis that is within the drug's approved indication(s) to qualify for no-cost medications from OPAF. This means patients who are being treated with Otsuka medications for conditions not indicated in the medication's approved Prescribing Information will not qualify for free treatment. Please contact a Dedicated Patient Case Coordinator by dialing 1-855-727-6274, Monday-Friday, 8 AM-8 PM (ET) if further clarification is needed.

Patients that reside in the United States and US territories may register for and use the features of OPAF Care Connect Patient Portal.

Healthcare Professionals that practice in the United States and Us territories may register for and use the features of OPAF Care Connect Prescriber Portal.

Yes, a patient can create an account and start the application process to see if they qualify for assistance with OPAF. The patient must have been prescribed an Otsuka branded medication. Once the patient submits the application via the OPAF Care Connect Patient Portal, the OPAF team will work with the indicated Healthcare Provider [HCP] to fulfill the additional Prescriber requirements. Please remember to upload the required documentation for processing which includes income documentation, US home address documentation, and insurance denial information if available.

If you need any additional help, please call OPAF at 1-855-727-6274, Monday-Friday, 8 AM-8 PM (ET).

During this extraordinary time, Otsuka Patient Assistance Foundation, Inc. (OPAF) continues to assist patients that have been prescribed an Otsuka medication. Our foundation is open during our standard business hours of Monday-Friday 8am-8pm EDT.

If you are facing a hardship because of the COVID-19 crisis such as:

  • Changes to your employment status such as losing your job or being temporarily furloughed;
  • Changes in your insurance or medication costs;

Please contact OPAF immediately at 1-855-727-6274 to discuss potential assistance.

We are continuing our goal of helping patients that are facing difficulty accessing their prescribed Otsuka medication.

April 2020PAUS20EUC0002

During this extraordinary time, Otsuka Patient Assistance Foundation, Inc. (OPAF) continues to assist patients that have been prescribed an Otsuka medication. Our foundation is open during our standard business hours of Monday-Friday 8am-8pm EDT.

If you are facing a hardship because of the COVID-19 crisis such as:

  • Changes to your employment status such as losing your job or being temporarily furloughed;
  • Changes in your insurance or medication costs;

Please contact OPAF immediately at 1-855-727-6274 to discuss potential assistance.

We are continuing our goal of helping patients that are facing difficulty accessing their prescribed Otsuka medication.

April 2020PAUS20EUC0002

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:

  • Federal Income Tax Return (1040, etc.)
  • W-2 from previous tax year
  • 1099-MISC form
  • Two most recent paystubs
  • Social Security award letter
  • Disability income information
  • Unemployment benefits letter
  • Letter from employer on company letterhead

The application must also include an acceptable proof of a US address. Acceptable documentation includes one of the following:

  • Social Security number
  • State driver’s license or State ID
  • US birth certificate
  • US passport
  • Mortgage statement or rental agreement
  • Two (2) utility bills
  • Foreign passport with US visa
  • I-94 form with photograph
  • US military ID
  • US certificate of naturalization or citizenship
  • Green card
  • Alien registration card

The application must also include insurance denial documentation. Acceptable documentation includes one of the following:

  • Explanation of benefits
  • Insurance statement
  • Prior authorization denial letter

Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Case Coordinator without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.

Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.

To setup your OPAF secure message account follow the steps below:

  • Click on the (button or envelope) below to start the process
  • The system will prompt you to enter your email address as a "New to SecureContact"
  • A verification email will be sent to the email address that you entered
  • In your email inbox, you will find a message from "[email protected]"
  • Open this message and click on the link to activate your account
  • Complete the account activation by creating a password
  • Your account is active, and you can securely send a message to OPAF

If you have any questions, please contact OPAF at 1-855-727-6274 8:00 AM - 8:00 PM EST.

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA®(tolvaptan) tablets.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.